TGF‐β1 is expressed in naevi, primary and metastatic melanoma, whereas TGF‐β2 and β3 expression increases in parallel with tumour progression,22 and levels of TGF‐β1 and β2 are elevated in the plasma of patients with metastatic melanoma.20 Here, TGFB2 is linked to neoplasm.